Costs and quality of life of multiple sclerosis in Spain

By Kobelt Gisela   Berg J.   Lindgren P.   Izquierdo G.   Sánchez-Soliño O.   Pérez-Miranda J.   Casado M.  

The European Journal of Health Economics, Vol. 7, Iss. 2, 2006-07 ,pp. : 65-74

Springer Publishing Company

Access to resources Recommend Favorite

Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study

By  

ACTA PSYCHIATRICA SCANDINAVICA, Vol. 105, Iss. 1, 2002-01 ,pp. : 42-54

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Relationship of Antipsychotic Medication Class and Adherence with Treatment Outcomes and Costs for Florida Medicaid Beneficiaries with Schizophrenia

By Becker Marion   Young M.   Ochshorn Ezra   Diamond Ronald  

Administration and Policy in Mental Health, Vol. 34, Iss. 3, 2007-05 ,pp. : 307-314

Springer Publishing Company

Access to resources Recommend Favorite

A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany

By Beard Stephen   Maciver Fiona   Clouth Johannes   Rüther Eckart  

The European Journal of Health Economics, Vol. 7, Iss. 3, 2006-09 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia

By Järbrink Krister   Kreif Noemi   Benedict Agnes   Locklear Julie  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 709-716

Informa Healthcare

Access to resources Recommend Favorite